Literature DB >> 12053044

Duration of antibiotic therapy for the treatment of shunt infection: a surgeon and patient survey.

Adam S Arthur1, William E Whitehead, John R W Kestle.   

Abstract

The ideal duration of antibiotic treatment for shunt infection remains a major unanswered question in pediatric neurosurgery. To date, no study has objectively determined the best length of treatment, i.e. that which minimizes both the length of hospital stay and the chance of reinfection. This study was undertaken to determine whether an increase in reinfection risk would be tolerated if the duration of therapy were shortened. Sixty-one members of the American Society of Pediatric Neurosurgeons (44 responding) and 831 patients or parents of patients with shunts (385 responding) were surveyed using similar questionnaires. Sixty-four percent of neurosurgeons (28/44) and 54% of patients (178/325) responding to the survey would tolerate an increased reinfection risk in order to gain a shorter duration of treatment. These data support the feasibility of a planned randomized study to determine the ideal length of antibiotic treatment for shunt infection. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12053044     DOI: 10.1159/000058429

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  3 in total

1.  Prophylactic antibiotics in pediatric shunt surgery.

Authors:  N Biyani; G Grisaru-Soen; P Steinbok; S Sgouros; S Constantini
Journal:  Childs Nerv Syst       Date:  2006-05-18       Impact factor: 1.475

2.  A standardized protocol to reduce cerebrospinal fluid shunt infection: the Hydrocephalus Clinical Research Network Quality Improvement Initiative.

Authors:  John R W Kestle; Jay Riva-Cambrin; John C Wellons; Abhaya V Kulkarni; William E Whitehead; Marion L Walker; W Jerry Oakes; James M Drake; Thomas G Luerssen; Tamara D Simon; Richard Holubkov
Journal:  J Neurosurg Pediatr       Date:  2011-07       Impact factor: 2.375

3.  The economic impact of ventriculoperitoneal shunt failure.

Authors:  Chevis N Shannon; Tamara D Simon; Gavin T Reed; Frank A Franklin; Russell S Kirby; Meredith L Kilgore; John C Wellons
Journal:  J Neurosurg Pediatr       Date:  2011-12       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.